AEMD · Aethlon Medical Inc. Common Stock
View on chartInsiders & Stakes
| JOHNSON SABRINA MARTUCCI Director | ▼ Sell | Tax Withholding | 33,642 Shares held | 3/31/2022 | View profile |
| Rossetti Angela Director | ▲ Buy | Grant | 26,207 Shares held | 4/17/2026 | View profile |
| BROENNIMAN EDWARD G Director | ▼ Sell | Tax Withholding | 22,363 Shares held | 6/30/2026 | View profile |
| Shah Chetan Director | ▼ Sell | Tax Withholding | 20,840 Shares held | 6/30/2026 | View profile |
| Gikakis Nicolas Director | ▼ Sell | Tax Withholding | 20,663 Shares held | 6/30/2026 | View profile |
Transaction History
| Shah Chetan | ▼ Sell | Tax Withholding | 2,182 | $2K | 6/30/2026 |
| Gikakis Nicolas | ▼ Sell | Tax Withholding | 2,182 | $2K | 6/30/2026 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 1,091 | $895 | 6/30/2026 |
| Gikakis Nicolas | ▲ Buy | Grant | 21,815 | $50K | 4/17/2026 |
| Rossetti Angela | ▲ Buy | Grant | 21,815 | $50K | 4/17/2026 |
| Shah Chetan | ▲ Buy | Grant | 21,815 | $50K | 4/17/2026 |
| BROENNIMAN EDWARD G | ▲ Buy | Grant | 21,815 | $50K | 4/17/2026 |
| Shah Chetan | ▼ Sell | Tax Withholding | 178 | $390 | 3/31/2026 |
| Gikakis Nicolas | ▼ Sell | Tax Withholding | 178 | $390 | 3/31/2026 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 89 | $195 | 3/31/2026 |
| Gikakis Nicolas | ▼ Sell | Tax Withholding | 179 | $496 | 12/31/2025 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 89 | $247 | 12/31/2025 |
| Shah Chetan | ▼ Sell | Tax Withholding | 179 | $496 | 12/31/2025 |
| Shah Chetan | ▼ Sell | Tax Withholding | 1,786 | $1K | 9/30/2025 |
| Gikakis Nicolas | ▼ Sell | Tax Withholding | 1,786 | $1K | 9/30/2025 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 893 | $669 | 9/30/2025 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 893 | $1K | 6/30/2025 |
| Gikakis Nicolas | ▼ Sell | Tax Withholding | 1,786 | $2K | 6/30/2025 |
| Shah Chetan | ▼ Sell | Tax Withholding | 1,786 | $2K | 6/30/2025 |
| Shah Chetan | ▲ Buy | Grant | 142,857 | $51K | 4/23/2025 |
| BROENNIMAN EDWARD G | ▲ Buy | Grant | 142,857 | $50K | 4/23/2025 |
| Rossetti Angela | ▲ Buy | Grant | 142,857 | $50K | 4/23/2025 |
| Gikakis Nicolas | ▲ Buy | Grant | 142,857 | $50K | 4/23/2025 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 1,645 | $589 | 3/31/2025 |
| Shah Chetan | ▼ Sell | Tax Withholding | 3,289 | $1K | 3/31/2025 |
| Gikakis Nicolas | ▼ Sell | Tax Withholding | 3,289 | $1K | 3/31/2025 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 1,645 | $1K | 12/31/2024 |
| Shah Chetan | ▼ Sell | Tax Withholding | 3,289 | $3K | 12/31/2024 |
| Gikakis Nicolas | ▼ Sell | Tax Withholding | 3,289 | $3K | 12/31/2024 |
| Gikakis Nicolas | ▼ Sell | Tax Withholding | 3,289 | $2K | 9/30/2024 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 1,645 | $767 | 9/30/2024 |
| Shah Chetan | ▼ Sell | Tax Withholding | 3,289 | $2K | 9/30/2024 |
| Shah Chetan | ▼ Sell | Tax Withholding | 3,289 | $2K | 6/28/2024 |
| Gikakis Nicolas | ▼ Sell | Tax Withholding | 5,244 | $3K | 6/28/2024 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 1,645 | $821 | 6/28/2024 |
| Gikakis Nicolas | ▲ Buy | Grant | 32,894 | $50K | 4/16/2024 |
| Rossetti Angela | ▲ Buy | Grant | 32,894 | $50K | 4/16/2024 |
| Shah Chetan | ▲ Buy | Grant | 32,894 | $50K | 4/16/2024 |
| BROENNIMAN EDWARD G | ▲ Buy | Grant | 32,894 | $50K | 4/16/2024 |
| Gikakis Nicolas | ▼ Sell | Tax Withholding | 1,954 | $3K | 3/29/2024 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 1,163 | $2K | 3/29/2024 |
| Shah Chetan | ▼ Sell | Tax Withholding | 1,163 | $2K | 3/29/2024 |
| Gikakis Nicolas | ▼ Sell | Tax Withholding | 1,954 | $4K | 12/29/2023 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 1,163 | $3K | 12/29/2023 |
| Shah Chetan | ▼ Sell | Tax Withholding | 1,163 | $3K | 12/29/2023 |
| Shah Chetan | ▼ Sell | Tax Withholding | 11,628 | $3K | 9/29/2023 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 11,628 | $3K | 9/29/2023 |
| Gikakis Nicolas | ▼ Sell | Tax Withholding | 19,541 | $4K | 9/29/2023 |
| Gikakis Nicolas | ▲ Buy | Grant | 195,414 | $0 | 7/3/2023 |
| Shah Chetan | ▼ Sell | Tax Withholding | 11,628 | $4K | 6/30/2023 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 11,628 | $4K | 6/30/2023 |
| Shah Chetan | ▲ Buy | Grant | 116,279 | $0 | 4/28/2023 |
| Rossetti Angela | ▲ Buy | Grant | 116,279 | $0 | 4/28/2023 |
| BROENNIMAN EDWARD G | ▲ Buy | Grant | 116,279 | $0 | 4/28/2023 |
| Shah Chetan | ▼ Sell | Tax Withholding | 3,425 | $1K | 3/31/2023 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 3,425 | $1K | 3/31/2023 |
| Shah Chetan | ▼ Sell | Tax Withholding | 3,425 | $942 | 12/30/2022 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 3,425 | $942 | 12/30/2022 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 6,849 | $4K | 9/30/2022 |
| Shah Chetan | ▼ Sell | Tax Withholding | 6,849 | $4K | 9/30/2022 |
| Rossetti Angela | ▲ Buy | Grant | 51,370 | $0 | 9/15/2022 |
| Shah Chetan | ▲ Buy | Grant | 34,247 | $0 | 9/15/2022 |
| BROENNIMAN EDWARD G | ▲ Buy | Grant | 34,247 | $0 | 9/15/2022 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 2,430 | $4K | 3/31/2022 |
| Shah Chetan | ▼ Sell | Tax Withholding | 2,430 | $4K | 3/31/2022 |
| JOHNSON SABRINA MARTUCCI | ▼ Sell | Tax Withholding | 2,430 | $4K | 3/31/2022 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 2,430 | $5K | 12/31/2021 |
| Shah Chetan | ▼ Sell | Tax Withholding | 2,430 | $5K | 12/31/2021 |
| JOHNSON SABRINA MARTUCCI | ▼ Sell | Tax Withholding | 2,430 | $5K | 12/31/2021 |
| BROENNIMAN EDWARD G | ▼ Sell | Tax Withholding | 2,430 | $9K | 9/30/2021 |
| JOHNSON SABRINA MARTUCCI | ▼ Sell | Tax Withholding | 2,430 | $9K | 9/30/2021 |
| Shah Chetan | ▼ Sell | Tax Withholding | 2,430 | $9K | 9/30/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
AEMD Holds Shareholder/Analyst Call, Transcript Released
Aethlon Medical Inc. released a transcript of its recent shareholder and analyst call. The prepared remarks provided management’s update on company developments and outlook. The release gives investors additional information to assess the business amid the stock’s elevated RSI reading.
AEMD Holds Shareholder/Analyst Call, Transcript Released. Aethlon Medical Inc. released a transcript of its recent shareholder and analyst call. The prepared remarks provided management’s update on company developments and outlook. The release gives investors additional information to assess the business amid the stock’s elevated RSI reading.